Hyperfine, Inc. (HYPR)
| Market Cap | 103.00M |
| Revenue (ttm) | 10.59M |
| Net Income (ttm) | -40.05M |
| Shares Out | 97.17M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 103,214 |
| Open | 1.090 |
| Previous Close | 1.070 |
| Day's Range | 1.030 - 1.110 |
| 52-Week Range | 0.533 - 2.220 |
| Beta | 1.08 |
| Analysts | Strong Buy |
| Price Target | 1.28 (+20.76%) |
| Earnings Date | Nov 13, 2025 |
About HYPR
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredi... [Read more]
Financial Performance
In 2024, Hyperfine's revenue was $12.89 million, an increase of 16.84% compared to the previous year's $11.03 million. Losses were -$40.72 million, -7.95% less than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for HYPR stock is "Strong Buy." The 12-month stock price target is $1.28, which is an increase of 20.76% from the latest price.
News
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Hyperfine, Inc. ( HYPR) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Webb Campbell Maria Sainz - CEO, President & Director Brett Hale - Chief Administrative Officer, CFO, ...
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine today announced third quarter 2025 financial results and provided a business update.
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches study to assess Swoop® System use in neurosurgical ORs, advancing accessible brain MRI across care settings.
Hyperfine Announces Pricing of $17.5 Million Public Offering
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has priced its previously announced underwritten public offering of 14,000,000 shares...
Hyperfine Announces Proposed Public Offering
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced that it has commenced an underwritten public offering of its Class A common stock or, in...
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine Swoop® system, via partner UpCare, earns national referencing from UniHA, France's top hospital purchasing cooperative.
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches a subscription-based platform designed to empower researchers and developers advancing access and innovation in portable MRI.
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software.
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Co...
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered p...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine hits 100-patient milestone in portable MRI study, accelerating access to brain imaging in neurology clinics with next-gen Swoop® system.
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--First patients enrolled in PRIME study at Yale School of Medicine, aiming to evaluate the potential of AI-powered portable MRI tech in the ED setting.
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference
TORONTO--(BUSINESS WIRE)--Swoop® AI-powered portable MRI system shows 100% sensitivity for ARIA-E detection in Lecanemab patients (CARE PMR study data presented at AAIC 2025).
Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care
GUILFORD, Conn.--(BUSINESS WIRE)--New studies showcase the Swoop® MRI system's potential role in expanding access to dementia care and monitoring Alzheimer's treatment.
Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine begins commercial launch of Optive AI™ software, bringing substantial image quality improvements to Swoop® systems.
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces first sales of next-gen Swoop® MRI system, powered by Optive AI™ software, to top U.S. hospitals following FDA clearance.
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable M...
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...